Eli Lilly and Company

  • Drawing of a network on a global

    The Strategic Pharma-Academic Research Consortium (SPARC), an organization to spark innovative collaborations in discovery and 'pre-competitive', disease target discovery stage between academic research institutions who are members of the NIH CTSA network and the biopharmaceutical industry. The consortium was established by 4 Midwestern CTSA Hubs as founding partners in 2014, along with two large